Content
11/18/2024
San Antonio, TX USA
Revisto
completed $4 million Seed Round funding. Investors include
LiveOak Ventures (lead), Arkin Digital Health, Eli Lilly and Company, Tau Ventures.
About
Revisto is a leading AI-powered platform revolutionizing the medical, legal, and regulatory (MLR) review process for pharmaceutical marketing materials. Based in Austin, Texas, Revisto leverages cutting-edge AI technology and industry expertise to streamline marketing operations, reduce costs, and eliminate compliance risks for life sciences companies. By optimizing the release cycle and improving quality and consistency, Revisto plays a pivotal role in enabling the next generation of data-driven, personalized and engaging life sciences marketing.
Startup
Sector:
Software
Digital Health
Download StockFan App
Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
